// App-Quantinova.ai

e15134 : Comparison of efficacy and tolerability of weekly adjuvant chemotherapy for colorectal cancer (CRC) using folinic acid with fluorouracil dosed at 425 mg/m2 or 370 mg/m2.

Researchers

Presenter

  • Michael B. Jameson

Principal Investigators

  • Nicola Jane Lawrence

  • Ian C. Kennedy

  • Michelle Anne Head

  • Sanjeev Deva

Medical Centers

  • Waikato Hospital, Hamilton, New Zealand

  • Auckland City Hospital, Auckland, New Zealand

  • Tauranga Hospital, Tauranga, New Zealand

Locations

  • New Zealand

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

  • Solid malignancies

Biomarkers

  • Fibroblast growth factor receptor 3

Drug/Treatment

  • Fluorouracil

  • Adrucil injection

  • L-leucovorin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved